These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 30640551

  • 1. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement.
    Karami Z, Saghatchi Zanjani MR, Rezaee S, Rostamizadeh K, Hamidi M.
    Drug Dev Ind Pharm; 2019 May; 45(5):736-744. PubMed ID: 30640551
    [Abstract] [Full Text] [Related]

  • 2. Indinavir-Loaded Nanostructured Lipid Carriers to Brain Drug Delivery: Optimization, Characterization and Neuropharmacokinetic Evaluation.
    Nasiri M, Azadi A, Zanjani MRS, Hamidi M.
    Curr Drug Deliv; 2019 May; 16(4):341-354. PubMed ID: 30674257
    [Abstract] [Full Text] [Related]

  • 3. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
    Kurd M, Sadegh Malvajerd S, Rezaee S, Hamidi M, Derakhshandeh K.
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
    [Abstract] [Full Text] [Related]

  • 4. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M.
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [Abstract] [Full Text] [Related]

  • 5. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
    Jiang Y, Liu C, Zhai W, Zhuang N, Han T, Ding Z.
    Int J Nanomedicine; 2019 Aug; 14():9217-9234. PubMed ID: 31819426
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.
    Rhame FS, Rawlins SL, Petruschke RA, Erb TA, Winchell GA, Wilson HM, Edelman JM, Abramson MA.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4200-8. PubMed ID: 15504842
    [Abstract] [Full Text] [Related]

  • 7. Brain delivery of transferrin coupled indinavir submicron lipid emulsions--pharmacokinetics and tissue distribution.
    Prabhakar K, Afzal SM, Kumar PU, Rajanna A, Kishan V.
    Colloids Surf B Biointerfaces; 2011 Sep 01; 86(2):305-13. PubMed ID: 21565469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic and intestinal contributions to pharmacokinetic interaction of indinavir with amprenavir, nelfinavir and saquinavir in rats.
    Gao W, Kishida T, Kageyama M, Kimura K, Yoshikawa Y, Shibata N, Takada K.
    Antivir Chem Chemother; 2002 Jan 01; 13(1):17-26. PubMed ID: 12180646
    [Abstract] [Full Text] [Related]

  • 14. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
    Wu Y, Zhang B, Kebebe D, Guo L, Guo H, Li N, Pi J, Qi D, Guo P, Liu Z.
    Pharm Dev Technol; 2019 Oct 01; 24(8):982-991. PubMed ID: 31107131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.